Drug therapy improves treatment of head and neck cancers
This article was originally published in Clinica
Adding weekly chemotherapy to radiation therapy for head and neck cancers increased three-year survival rates from as little as 20% to nearly 50%, according to a University of Maryland study. The findings are preliminary, however, and must be confirmed in a larger, randomised trial of the technique, the researchers warned at the American Society for Therapeutic Radiology meeting in San Antonio, Texas last week.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.